ZA201302996B - Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate - Google Patents

Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate

Info

Publication number
ZA201302996B
ZA201302996B ZA2013/02996A ZA201302996A ZA201302996B ZA 201302996 B ZA201302996 B ZA 201302996B ZA 2013/02996 A ZA2013/02996 A ZA 2013/02996A ZA 201302996 A ZA201302996 A ZA 201302996A ZA 201302996 B ZA201302996 B ZA 201302996B
Authority
ZA
South Africa
Prior art keywords
carboxamido
pyrrolo
pyrimidin
aminomethyl
piperidine
Prior art date
Application number
ZA2013/02996A
Other languages
English (en)
Inventor
Paul Margaret Susan De
Haiming Zhang
Qun Li
Original Assignee
Lexicon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lexicon Pharmaceuticals Inc filed Critical Lexicon Pharmaceuticals Inc
Publication of ZA201302996B publication Critical patent/ZA201302996B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA2013/02996A 2010-11-05 2013-04-24 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate ZA201302996B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41060210P 2010-11-05 2010-11-05
PCT/US2011/059086 WO2012061565A1 (en) 2010-11-05 2011-11-03 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate

Publications (1)

Publication Number Publication Date
ZA201302996B true ZA201302996B (en) 2014-06-25

Family

ID=45002136

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2013/02996A ZA201302996B (en) 2010-11-05 2013-04-24 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate

Country Status (16)

Country Link
US (1) US8735408B2 (enExample)
EP (1) EP2635584A1 (enExample)
JP (1) JP2013541588A (enExample)
KR (1) KR20140003433A (enExample)
CN (1) CN103298815A (enExample)
AR (1) AR083756A1 (enExample)
AU (1) AU2011323371A1 (enExample)
BR (1) BR112013011094A2 (enExample)
CA (1) CA2817112A1 (enExample)
IL (1) IL225884A0 (enExample)
MX (1) MX2013004923A (enExample)
RU (1) RU2013125755A (enExample)
SG (1) SG190098A1 (enExample)
TW (1) TW201302754A (enExample)
WO (1) WO2012061565A1 (enExample)
ZA (1) ZA201302996B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015150337A1 (en) 2014-04-01 2015-10-08 Amakem Nv Lim kinase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI439457B (zh) * 2007-09-28 2014-06-01 Lexicon Pharmaceuticals Inc (s)-2-胺基-3-(4-(2-胺基-6-((r)-1-(4-氯-2-(3-甲基-1h-吡唑-1-基)苯基)-2,2,2-三氟乙氧)-嘧啶-4-基)苯基)丙酸乙酯之固體形式與其使用方法
JP5575110B2 (ja) 2008-04-21 2014-08-20 レクシコン ファーマシューティカルズ インコーポレイテッド Limk2阻害剤、それらを含む組成物、及びそれらの使用の方法

Also Published As

Publication number Publication date
US8735408B2 (en) 2014-05-27
CN103298815A (zh) 2013-09-11
SG190098A1 (en) 2013-06-28
CA2817112A1 (en) 2011-11-05
KR20140003433A (ko) 2014-01-09
JP2013541588A (ja) 2013-11-14
MX2013004923A (es) 2013-06-28
WO2012061565A1 (en) 2012-05-10
US20120122898A1 (en) 2012-05-17
AR083756A1 (es) 2013-03-20
RU2013125755A (ru) 2014-12-10
EP2635584A1 (en) 2013-09-11
IL225884A0 (en) 2013-07-31
AU2011323371A1 (en) 2013-05-23
BR112013011094A2 (pt) 2016-08-23
TW201302754A (zh) 2013-01-16

Similar Documents

Publication Publication Date Title
SI2432472T1 (sl) 3-(4-(7H-pirolo(2,3-d)pirimidin-4-il)-1H-pirazol-1-il)oktan- ali heptan-nitril kot inhibitorji JAK
SI3686194T1 (sl) Spojine 2-(2,4,5-substituiranega-anilino)pirimidina
ZA201008486B (en) 5-substituted isoindoline compounds
EP2353125A4 (en) USER AUTHENTICATION FOR SOCIAL NETWORKS
GB201012105D0 (en) Novel pyrimidine compounds
AP2010005364A0 (en) Novel heterocyclic compounds.
PL2621903T3 (pl) Związki n-heteroarylu
EP2699091A4 (en) 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS
IL257977A (en) A process for the preparation of 3-(1-amino-2-methylpentane-3-yl)substituted phenyl compounds
ZA201301385B (en) Therapeutic uses of 1-[2,4-dimethyl-phenylsulfanyl)phenyl]piperazine
IL214110A0 (en) 2,3-diaryl-or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
PT2523963E (pt) Derivados de oxazolopirimidina substituídos em 2,5 como agonistas do edg-1
ZA201302996B (en) Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
HK1196618B (en) 3-(pyrimidin-4-yl)-oxazolidin-2-ones as inhibitors of mutant idh
HK1184434B (en) Process for the preparation of substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
PL393096A1 (pl) Sposób otrzymywania nowych związków - pochodnych 3-[5,5-bis(piwaloiloksymetylo)pirolidyn-2-ylo]-1H-indolu
HK1188394A (en) Formulations of phenyl uracil compounds
GB201009514D0 (en) Novel heterocyclic compounds
GB201021416D0 (en) Novel heterocyclic compounds
AU2012900131A0 (en) "Heterocyclic compounds"